SIR-Spheres® Y-90 resin microspheres
About SIR-Spheres
SIR-Spheres Y-90 resin microspheres are a permanent implant and intended for single use only.
The high number of microspheres provides a uniform radiation distribution, enabling treatment of solitary and multifocal liver tumors.1–3
With a specific density close to that of red blood cells,1 they are carried by the blood flow, penetrating deep into the tumor microvasculature.
Yttrium-90 has two inherent safety features for staff and patients:
- the minimal penetration depth of beta radiation emissions through tissue and air
- the relatively short half-life of 64.1 hours
SIR-Spheres Y-90 resin microspheres can therefore be delivered in a slow, deliberate manner
- to achieve an even distribution
- to maximize the number of microspheres delivered
- to optimize tumor coverage - even in patients with extensive disease
Product Features |
|||
Manufacturer | Sirtex Medical Pty. Ltd | ||
Isotope | Yttrium-90 | ||
Decay product | Zirconium-90 | ||
Composition | Resin (sulfonated divinyl benzene-styrene copolymer) | ||
Specific density | 1.125 - 1.6 g/ml (comparable to red blood cells) | ||
Diameter | 32±10 µm | ||
T1/2 | 64.1 h (94% within 11 days) | ||
Penetration in tissue | 2.5 mm (mean) | ||
Presentation of activity |
|
||
No. of microspheres per vial |
|
Additional Product Information
- Sirtex internal data
- Burrill J et al. J Nucl Med Radiat Ther 2011; 2:107. doi:10.4172/2155-9619.1000107.
- Chiesa et al. J Nuc Med Molmaging 2011; 55: 168–197.